Molecule interferes with the internal regulation of cancer cells, causing them to self-destruct.

Study reveals how they restore cognitive functions impaired by chemotherapy.

Protein may be to blame; study suggests combination therapies could overcome drug resistance.

UCLA research played key role in development of Ibrance, targeting estrogen-receptor–positive breast cancer.

Researchers from UC San Diego and UC San Francisco join forces to determine how all of the components of a cancer cell interact.

In the face of a terminal diagnosis, the UC Berkeley grad has taken control of her life — and death.

Originating from indigenous Americans, variant reduces risk by 40 to 80 percent.

Researchers are using biological accelerator mass spectrometry to see how cancer patients respond to specific chemotherapy.

Drug that turns on the immune system to fight deadly cancers is a ‘game changer,’ says study’s principal investigator.

Researchers find that there are 466 brands online and 10 new brands introduced every month, making regulating the market increasingly complex.

Gene variants may promote overall health while increasing risk of gliomas.

Doctors see successes with an experimental drug in two types of cancer with historically low survival rates: metastatic melanoma and lung cancer.